|Articles|June 1, 2008

Pharmaceutical Executive

  • Pharmaceutical Executive-06-01-2008
  • Volume 0
  • Issue 0

James Galeota, Merck

S

James Galeota

SVP, General Manager, Diabetes and Obesity, Merck

BIGGEST ACCOMPLISHMENT: Establishing Merck's diabetes franchise

ADMIRES: Those that can help others live up to their potential

On stopping the silos:

Commercialization is not about discreet disciplines. At Merck, I have been able to see into different parts of the company and see the value that can be created when all the divisions are synchronized—when you have teams that are aligned around objectives, sharing the same measures of success, holding each other accountable, and working together to solve complex problems.

James Galeota

Articles in this issue

almost 18 years ago

Mary Szela, Abbott

almost 18 years ago

Mightier Than the Sword

almost 18 years ago

Keeshia Muhammad, Teva Specialty Pharmaceuticals

almost 18 years ago

Eric Floyd, Cephalon

almost 18 years ago

Kimberly Park, Vice President Sales and Marketing, PriCara, Ortho-McNeil Janssen Pharmaceuticals

almost 18 years ago

Nancy Phelan, Wyeth

almost 18 years ago

Tightening the Chain

almost 18 years ago

Kurt Graves, Vertex

almost 18 years ago

Wendy Niebler, Shire

almost 18 years ago

Perfectly Imperfect

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!

Related Content